Impact of pneumococcal conjugate vaccines introduction on antibiotic resistance of Streptococcus pneumoniae meningitis in children aged 5 years or younger, Israel, 2004 to 2016

BACKGROUND: Empiric treatment of pneumococcal meningitis includes ceftriaxone with vancomycin to overcome ceftriaxone resistant disease. The addition of vancomycin bears a risk of adverse events, including increased antibiotic resistance. We assessed antibiotic resistance rates in pneumococcal menin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Shimol, Shalom, Givon-Lavi, Noga, Greenberg, David, Stein, Michal, Megged, Orli, Bar-Yochai, Avihu, Negari, Shahar, Dagan, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341944/
https://www.ncbi.nlm.nih.gov/pubmed/30482264
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.47.1800081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341944/
https://www.ncbi.nlm.nih.gov/pubmed/30482264
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.47.1800081

Ejemplares similares